Quick Summary:
The global C-Reactive Protein Testing market's evolution and trends are at the heart of our latest report. With an estimated market size of US$5.4 Billion in 2022, this field is expected to self-adjust and standardize to a size of US$5.3 Billion by 2030. This extensive research is key to mastering the dynamic progress of critical disease identification like cardiovascular and cancer.
As countries respond differently to healthcare pressures, our market research report uniquely positions your understanding of geographic market variations. We explore in-depth data on the U.S. market, forecast changes in China, and analyze the expected growth rates in vital regions such as Japan, Canada, and Germany. The critical insights provided will guide strategic decision-making, give competitive edge, and optimize opportunities within the C-Reactive Protein Testing market space. Capture the future of this market by accessing this comprehensive and forward-looking report.
Global C-Reactive Protein Testing Market to Reach $5.3 Billion by 2030
The global market for C-Reactive Protein Testing estimated at US$5.4 Billion in the year 2022, is projected to reach a revised size of US$5.3 Billion by 2030, growing at a CAGR of -0.2% over the analysis period 2022-2030. Cardiovascular Diseases, one of the segments analyzed in the report, is projected to record a 0% CAGR and reach US$1.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Cancer segment is readjusted to a revised -0.1% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at -0.2% CAGR
The C-Reactive Protein Testing market in the U.S. is estimated at US$1.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$950.5 Million by the year 2030 trailing a CAGR of -0.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.1% and -0.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 0% CAGR.Select Competitors (Total 43 Featured) -
- Abaxis, Inc.
- Abbott Laboratories
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Laboratory Corporation of America Holdings (LabCorp)
- Merck KgaA
- Quest Diagnostics, Inc.
- Randox Laboratories Ltd.
- Siemens Healthineers
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
| Report Attribute | Details |
|---|---|
| No. of Pages | 174 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 5.4 Billion |
| Forecasted Market Value ( USD | $ 5.3 Billion |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abaxis, Inc.
- Abbott Laboratories
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Laboratory Corporation of America Holdings (LabCorp)
- Merck KgaA
- Quest Diagnostics, Inc.
- Randox Laboratories Ltd.
- Siemens Healthineers
- Thermo Fisher Scientific, Inc.
